Skip to main content

Together we are beating cancer

Donate now

Cancer News

Prostate cancer

Around 47,700 men are diagnosed with prostate cancer in the UK each year, making it the most common cancer in men in the UK. It develops in the prostate, a walnut-sized gland found at the base of the bladder.
Showing 12 out of 238 results
Cancer Research UK logo

A unique multi-target experimental drug could treat a range of cancer types, according to research published in Clinical Cancer Research today. A unique multi-target experimental drug could treat a range of cancer types, according to research published in Clinical Cancer Research today.

by Cancer Research UK | News | 10 July 2012

10 July 2012

Cancer Research UK logo

A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK. A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK.

by Cancer Research UK | News | 31 May 2012

31 May 2012

Cancer Research UK logo

A newly-discovered protein found only in prostate cancer cells could be used as a marker of the disease and offer a new treatment target, according to a study in the British Journal of Cancer. A newly-discovered protein found only in prostate cancer cells could be used as a marker of the disease and offer a new treatment target, according to a study in the British Journal of Cancer.

by British Journal of Cancer | News | 30 May 2012

30 May 2012

Cancer Research UK logo

Latest figures from Cancer Research UK reveal that the number of men diagnosed with prostate cancer in the UK has risen above 40,000. Latest figures from Cancer Research UK reveal that the number of men diagnosed with prostate cancer in the UK has risen above 40,000.

by Cancer Research UK | News | 4 May 2012

4 May 2012

Cancer Research UK logo

Cancer Research UK scientists have discovered how blocking a key enzyme, which helps convert glucose into energy, could provide a new way to kill prostate cancer cells, according to a study published in the journal Cancer Discovery today (Thursday). Cancer Research UK scientists have discovered how blocking a key enzyme, which helps convert glucose into energy, could provide a new way to kill prostate cancer cells, according to a study published in the journal Cancer Discovery today (Thursday).

by Cancer Research UK | News | 22 March 2012

22 March 2012

Cancer Research UK logo

Cancer Research UK is extremely disappointed that the advanced prostate cancer drug, abiraterone, has been ruled too expensive for routine use by the Scottish Medicines Consortium (SMC). Cancer Research UK is extremely disappointed that the advanced prostate cancer drug, abiraterone, has been ruled too expensive for routine use by the Scottish Medicines Consortium (SMC).

by Cancer Research UK | News | 12 March 2012

12 March 2012